Morteza Saladian Medical Cente is categorized under Medical Centers in Los Angeles, CA and active since 2007.
Morteza Saladian Medical Cente was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 621112 by the NAICS.
If you are seeking more information, feel free to contact Othella Owens at the company’s single location by writing to 1127 Wilshire Boulevard # 600, Los Angeles, California CA 90017 or by phoning (213) 202-5920. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Morteza Saladian Medical Cente |
| Contact Person: | Othella Owens |
| Address: | 1127 Wilshire Boulevard # 600, Los Angeles, California 90017 |
| Phone Number: | (213) 202-5920 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621112 |
| Share This Business: |
Morteza Saladian Medical Cente was started in 2007 to provide professional Medical Centers under the SIC code 8011 and NAICS code 621112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Othella Owens for inquiries that concern Morteza Saladian Medical Cente by calling the company number (213) 202-5920, as your correspondence is most welcome. Additionally, the physical location of the single location of Morteza Saladian Medical Cente can be found at the coordinates as well as the street address 1127 Wilshire Boulevard # 600 in Los Angeles, California 90017.
For its online presence, you may visit Morteza Saladian Medical Cente’s website at and engage with its social media outlets through on Twitter and on Facebook.